Recent Quotes (30 days)

You have no recent quotes
chg | %

Pacgen Life Science Corp  

(Public, CVE:PBS)   Watch this stock  
Find more results for PBS
0.0000 (0.00%)
Jul 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.03 - 0.09
Open     -
Vol / Avg. 0.00/19,567.00
Mkt cap 1.84M
P/E     -
Div/yield     -
EPS 0.00
Shares 52.52M
Beta -0.71
Inst. own     -

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -17.97% 0.12%
Operating margin -31.52% -11.03%
EBITD margin - -10.24%
Return on average assets -2.68% 0.02%
Return on average equity -7.48% 0.10%
Employees 10 -
CDP Score - -


701 West Georgia St. Suite 1500
+1-604-4364388 (Phone)
+1-604-4364380 (Fax)

Website links


Pacgen Life Science Corporation (Pacgen) is a Canada-based life science technology company. The Company is focused on the commercialization of biomedical products and services. The Company has a license to develop and commercialize a novel antifungal called PAC-113. The Company's PAC-113 is a 12 amino-acid antimicrobial peptide. The Company, through General Biologicals Corporation (GBC), offers non-prescription over-the-counter (OTC) products containing PAC-113 in Taiwan, including cosmetic skin-care products, oral hygiene products and intimate hygiene products. The Company's PAC-113, which is an anti-fungal for the treatment of oral Candidiasis infections, completed a Phase IIb clinical program. Its products include Fit X1 Series, Electronic Pipettes and A+ Pipette Controller. Its Fit X1 401 is an automated pipetting system. Pacgen's A+ Pipette Controller is an electronic pipette controller for use with graduated and volumetric glass and plastic pipettes.

Officers and directors

Chung-Yu Wang Chairman of the Board, Chief Executive Officer
Christina Yip President, Chief Financial Officer, Director
Telvin Ju Ph.D. Lead Independent Director
Alan C. Savage Director
Jeng-Horng Her Ph.D. Independent Director
Min-Chih Hsuan Independent Director
Age: 60
Frederick Huang Independent Director